Grand River Aseptic Manufacturing (GRAM), a parenteral contract development and manufacturing organization (CDMO), has added Mary Lou Glotzbach to the GRAM team. She joins GRAM as senior business development manager serving the Mid-Atlantic.
 

“We are excited to welcome Mary Lou to our team,” said Dave Powell, vice president business development, GRAM. “Mary Lou is one of the top business development professionals in the CDMO industry, and her energy and passion will be invaluable as GRAM opens its new state-of-the-art manufacturing facility. Her experience and deep industry expertise are vital as we continue to grow. Having worked with Mary Lou for many years during her career, I look forward to working with her again and seeing all she will accomplish in driving our business development efforts.”
 
Prior to joining GRAM, Ms. Glotzbach held management roles at Pfizer CentreOne, Hospira and Abbott Laboratories. She is highly skilled in establishing relationships, accurately defining company’s needs, and driving opportunities to closure with the ability to guide support functions through due diligence and risk assessment processes.
 
GRAM produces parenteral therapeutics to various clients from clinical trials to commercialization.